We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSBC icon
3001
Old Second Bancorp
OSBC
$1.32B
$4K ﹤0.01%
323
-665
-67% -$8.83K
PAHC icon
3002
Phibro Animal Health
PAHC
$1.46B
$4K ﹤0.01%
113
-2,223
-95% -$78.9K
PAR icon
3003
PAR Technology
PAR
$727M
$4K ﹤0.01%
407
-3,735
-90% -$35.3K
PERI icon
3004
Perion Network
PERI
$378M
$4K ﹤0.01%
1,189
-980
-45% -$3.12K
PNRG icon
3005
PrimeEnergy Resources
PNRG
$302M
$4K ﹤0.01%
72
+1
+1% +$50
RCI icon
3006
Rogers Communications
RCI
$18.3B
$4K ﹤0.01%
56
-10,840
-99% -$565K
SAMG icon
3007
Silvercrest Asset Management
SAMG
$77.8M
$4K ﹤0.01%
+236
New +$3.6K
SB icon
3008
Safe Bulkers
SB
$778M
$4K ﹤0.01%
1,149
-11,310
-91% -$36.4K
SKT icon
3009
Tanger
SKT
$4.66B
$4K ﹤0.01%
152
-169
-53% -$4.18K
SSNC icon
3010
SS&C Technologies
SSNC
$18.6B
$4K ﹤0.01%
98
-91
-48% -$3.71K
TEI
3011
Templeton Emerging Markets Income Fund
TEI
$318M
$4K ﹤0.01%
+374
New +$4.31K
TEVA icon
3012
Teva Pharmaceuticals
TEVA
$40.5B
$4K ﹤0.01%
+192
New +$2.89K
TGB
3013
Trekor Metals
TGB
$2.99B
$4K ﹤0.01%
1,200
-451
-27% -$977
TPVG icon
3014
TriplePoint Venture Growth BDC
TPVG
$188M
$4K ﹤0.01%
+343
New +$4.63K
TRNS icon
3015
Transcat
TRNS
$877M
$4K ﹤0.01%
230
-452
-66% -$6.07K
UGP icon
3016
Ultrapar
UGP
$6.69B
$4K ﹤0.01%
334
-1,646
-83% -$19K
VLRS
3017
Controladora Vuela Compania de Aviacion
VLRS
$962M
$4K ﹤0.01%
444
-56
-11% -$556
XPRO icon
3018
Expro Ltd
XPRO
$1.83B
$4K ﹤0.01%
111
+5
+5% +$199
VIVS
3019
VivoSim Labs
VIVS
$1.27M
$4K ﹤0.01%
14
-45
-76% -$16.7K
EQC
3020
DELISTED
Equity Commonwealth
EQC
$4K ﹤0.01%
+120
New +$3.63K
WWE
3021
DELISTED
World Wrestling Entertainment
WWE
$4K ﹤0.01%
130
-4,034
-97% -$109K
ISEE
3022
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4K ﹤0.01%
1,288
-810
-39% -$2.28K
JNCE
3023
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4K ﹤0.01%
281
-3,325
-92% -$48.9K
MAXR
3024
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$4K ﹤0.01%
+52
New +$3.29K
CAJ
3025
DELISTED
Canon, Inc.
CAJ
$4K ﹤0.01%
106
+6
+6% +$224

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.